4
Changes in Ownership
Prelude Therapeutics Inc Filed Acc 0001562180-23-004517
CEO bought 1,900 shares at an average $5.15 ($9,790)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Vaddi Krishna CEO | 2023-05-24 | Purchase | +1,000 | $5.01 | $5,011 | 1,066,375 | D |
| Vaddi Krishna CEO | 2023-05-25 | Purchase | +900 | $5.31 | $4,779 | 1,067,275 | D |
| Open-market purchases · 1,900 sh · avg $5.15 · $9,790 | |||||||
Loading xslF345X04/primarydocument.xml…